The expression of c-Kit [16] and PDGFr-β [11,17] in a large number of pancreatic cancer biopsies was regarded as an encouraging sign and several clinical protocols involving imatinib were initiated. This evidence concerns the gene PDGFRB and pancreatic neoplasm.